In the Milwaukee debate, Hillary Clinton took pride in her role in a recent UN Security Council resolution on a Syrian ceasefire:

But I would add this. You know, the Security Council finally got around to adopting a resolution. At the core of that resolution is an agreement...

The American Congress is so incompetent that it is arbitrarily handing billions of dollars of U.S. tax revenues to Europe. The issue involves tax manipulation by America's top IT and pharmaceutical companies, including Google, Apple, Amazon, Microsoft, Gilead and others. These companies should be paying U.S. taxes that instead are...

There's no doubt that Hillary is the candidate of Wall Street. Even more dangerous, though, is that she is the candidate of the military-industrial complex. The idea that she is bad on the corporate issues but good on national security has it wrong. Her so-called foreign policy "experience" has been...

The Wall Street Journal has become the Fox News of print journalism, another entertainment outlet of the Murdoch media empire. The paper's opinion pages are lively, clever, and increasingly fact free. Business leaders looking for serious analysis instead of entertainment should turn to The Financial Times and other leading business...

Hillary Clinton's speech on ISIS to the Council on Foreign Relations (CFR) showed clearly what to expect in a Clinton presidency: more of the same. In her speech, Clinton doubled down on the existing, failed U.S. approach in the Middle East, the one she pursued as Secretary of...

This article first appeared in the Boston Globe.

Globalization is a positive and powerful force for good, if it is embedded in the right kind of ethical and legal framework. Yet the current draft of the Trans-Pacific Partnership is not worthy of a simple thumbs-up by the Congress....

Drug pricing has taken center stage in U.S. politics, and it's high time that it should. The soaring prices for drugs like Sovaldi ($1,000 a pill) and the recent hike of Deraprim from $13.50 to $750 a pill after the supplier was bought by a shady hedge-fund manager,...

Gilead has the cure for Hepatitis C (HCV) known as Sofosbuvir, which is taken alone or in combination with other drugs. Now we need a cure for Gilead. By pressing the company to make Sofosbuvir-based therapies accessible to all who need them, the Hepatitis C epidemic in America and worldwide...

I have been helping countries to overcome financial crises for 30 years, and have studied the economic crises of the twentieth century as background to my advisory work. In all crises, there is an inherent imbalance of power between creditor and debtor. Successful crisis management therefore depends on the creditor's...

Gilead Sciences is an American pharmaceutical company driven by unquenchable greed. The company is causing hundreds of thousands of Americans with Hepatitis C to suffer unnecessarily and many of them to die as the result of its monopolistic practices, while public health programs face bankruptcy. Gilead CEO John C. Martin...

NEW YORK -- The accord struck in Vienna to rein in Iran's nuclear activities has warmongers fulminating. Citizens worldwide should support U.S. President Barack Obama's brave effort to outmaneuver them, taking heart from the fact that the signatories include not just the United States, but all five permanent members of...

QUITO -- The Greek crisis is a tragedy for the country and a danger for the world economy. Germany is demanding that Greece continue to service its debts in full, even though Greece is clearly broke and the International Monetary Fund has noted the need for debt relief....

PARIS -- After months of wrangling, the showdown between Greece and its European creditors has come down to a standoff over pensions and taxes. Greece is refusing to acquiesce to demands by its creditors that it cut payments to the elderly and raise the value-added tax on their medicine and...

This post is co-authored with Sonia Sachs on behalf of the 1 Million CHW Campaign.

Public health officials and practitioners from around Africa and from international public and private organizations, businesses, and universities, met in Accra, Ghana June 9-11 to consider ways to scale-up the coverage of high-quality...

The good people of Dusseldorf, Germany, and specifically the IKB Bank, which specializes in loans to small and medium-size businesses, has kindly endowed Harvard University's engineering school with a gift of $400m. Harvard President Faust announced the endowment on June 3, the most generous in the University's history. Strangely, though,...

This post was co-authored with Lise Johnson, head of investment law and policy at the Columbia Center on Sustainable Investment and Lisa Sachs, director of the Columbia Center on Sustainable Investment.

The Obama Administration is now on track to get "fast track" legislation through the Senate, heading towards...

President Barack Obama is making a full-court press for two new international business agreements, one with Asian-Pacific countries known as Trans-Pacific Partnership (TPP) and the other with European countries known as the Trans-Atlantic Trade and Investment Partnership (TTIP). To secure these, he is calling on Congress to pass Trade Promotion...

Ficar mais rico, mas não mais feliz: é uma história familiar para pessoas e países. O objetivo do Relatório Mundial da Felicidade, agora em sua terceira edição, é lembrar governos, sociedade civil e indivíduos que, sozinha, a renda não garante nosso bem-estar. A verdadeira felicidade depende de capital...

Getting richer but not happier: It's a familiar story, for people and for nations. The purpose of the World Happiness Report, now in its third edition for 2015, is to remind governments, civil society, and individuals that income alone cannot secure our well-being. True happiness depends on social...

America is the land of breakthrough science -- and health care scams. The two seem to go hand in hand in the case of the new hepatitis C virus (HCV) cure named sofosbuvir, sold under the brand name Sovaldi by the drug company Gilead Sciences. There is no question that...